These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
290 related articles for article (PubMed ID: 7604786)
1. Improvement of myocardial perfusion by short-term fluvastatin therapy in coronary artery disease. Eichstädt HW; Eskötter H; Hoffman I; Amthauer HW; Weidinger G Am J Cardiol; 1995 Jul; 76(2):122A-125A. PubMed ID: 7604786 [TBL] [Abstract][Full Text] [Related]
2. Fluvastatin in severe hypercholesterolemia: analysis of a clinical trial database. Peters TK Am J Cardiol; 1995 Jul; 76(2):71A-75A. PubMed ID: 7604803 [TBL] [Abstract][Full Text] [Related]
3. Changes in plasma apolipoprotein B-containing lipoparticle levels following therapy with fluvastatin and cholestyramine. European Fluvastatin Study Group. Bard JM; Ose L; Hagen E; Duriez P; Pfister P; Fruchart JC; Dallongeville J Am J Cardiol; 1995 Jul; 76(2):65A-70A. PubMed ID: 7604802 [TBL] [Abstract][Full Text] [Related]
4. Comparison of fluvastatin versus pravastatin treatment of primary hypercholesterolemia. French Fluvastatin Study Group. Jacotot B; Benghozi R; Pfister P; Holmes D Am J Cardiol; 1995 Jul; 76(2):54A-56A. PubMed ID: 7604799 [TBL] [Abstract][Full Text] [Related]
5. Open-label study to assess the efficacy, safety, and tolerability of fluvastatin versus bezafibrate for hypercholesterolemia. Fanghänel G; Espinosa J; Olivares D; Sánchez L; Morales M; Martínez L; Macías G; Valdés E; Hernández G Am J Cardiol; 1995 Jul; 76(2):57A-61A. PubMed ID: 7604800 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of fluvastatin, a totally synthetic 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor. FLUENT Study Group. Fluvastatin Long-Term Extension Trial. Zavoral JH; Haggerty BJ; Winick AG; Bergmann SD Am J Cardiol; 1995 Jul; 76(2):37A-40A. PubMed ID: 7604795 [TBL] [Abstract][Full Text] [Related]
7. Beneficial effects of fluvastatin on myocardial blood flow at two time-points in hypercholesterolemic patients with coronary artery disease. Eichstädt HW; Abletshauser CB; Störk T; Weidinger G J Cardiovasc Pharmacol; 2000 May; 35(5):735-40. PubMed ID: 10813375 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of triple therapy (fluvastatin-bezafibrate-cholestyramine) for severe familial hypercholesterolemia. Leitersdorf E; Muratti EN; Eliav O; Peters TK Am J Cardiol; 1995 Jul; 76(2):84A-88A. PubMed ID: 7604807 [TBL] [Abstract][Full Text] [Related]
9. Effect of fluvastatin for safely lowering atherogenic lipids in renal transplant patients receiving cyclosporine. Holdaas H; Hartmann A; Stenstrøm J; Dahl KJ; Borge M; Pfister P Am J Cardiol; 1995 Jul; 76(2):102A-106A. PubMed ID: 7604781 [TBL] [Abstract][Full Text] [Related]
10. Outcome monitoring of fluvastatin in a Department of Veterans Affairs lipid clinic. Kellick KA; Burns K; McAndrew E; Haberl E; Hook N; Ellis A Am J Cardiol; 1995 Jul; 76(2):62A-64A. PubMed ID: 7604801 [TBL] [Abstract][Full Text] [Related]
11. Effects of fluvastatin and pravastatin on lipid profiles and thromboxane production in type IIa hypercholesterolemia. Milani M; Cimminiello C; Merlo B; Lorena M; Arpaia G; Bonfardeci G Am J Cardiol; 1995 Jul; 76(2):51A-53A. PubMed ID: 7604798 [TBL] [Abstract][Full Text] [Related]
12. Clinical efficacy of fluvastatin for hyperlipidemia in Japanese patients. Teramoto T; Goto Y; Kurokawa K; Nakamura H; Yoshida S; Saito Y; Nakaya N; Itakura H; Takaku F; Yamada N Am J Cardiol; 1995 Jul; 76(2):33A-36A. PubMed ID: 7604794 [TBL] [Abstract][Full Text] [Related]
13. Long-term efficacy with fluvastatin as monotherapy and combined with cholestyramine (a 156-week multicenter study). French-Dutch Fluvastatin Study Group. Jacotot B; Banga JD; Waite R; Peters TK Am J Cardiol; 1995 Jul; 76(2):41A-46A. PubMed ID: 7604796 [TBL] [Abstract][Full Text] [Related]
14. Clinical efficacy of fluvastatin in the long-term treatment of familial hypercholesterolemia. Koizumi J; Haraki T; Yagi K; Inazu A; Kajinami K; Miyamoto S; Ueda K; Ohta M; Takegoshi T; Takeda M Am J Cardiol; 1995 Jul; 76(2):47A-50A. PubMed ID: 7604797 [TBL] [Abstract][Full Text] [Related]
15. Effect of fluvastatin on intermediate density lipoprotein (remnants) and other lipoprotein levels in hypercholesterolemia. Broyles FE; Walden CE; Hunninghake DB; Hill-Williams D; Knopp RH Am J Cardiol; 1995 Jul; 76(2):129A-135A. PubMed ID: 7604788 [TBL] [Abstract][Full Text] [Related]
16. Delayed response of myocardial flow reserve to lipid-lowering therapy with fluvastatin. Guethlin M; Kasel AM; Coppenrath K; Ziegler S; Delius W; Schwaiger M Circulation; 1999 Feb; 99(4):475-81. PubMed ID: 9927392 [TBL] [Abstract][Full Text] [Related]
17. Effects of fluvastatin on lipid profile and apolipoproteins in Chinese patients with hypercholesterolemia. Tomlinson B; Mak TW; Tsui JY; Woo J; Shek CC; Critchley JA; Masarei JR Am J Cardiol; 1995 Jul; 76(2):136A-139A. PubMed ID: 7604789 [TBL] [Abstract][Full Text] [Related]
18. A preliminary report of the safety and efficacy of fluvastatin for hypercholesterolemia in renal transplant patients receiving cyclosporine. Goldberg RB; Roth D Am J Cardiol; 1995 Jul; 76(2):107A-109A. PubMed ID: 7604782 [TBL] [Abstract][Full Text] [Related]
19. Effects of fluvastatin on human biliary lipids. Tazuma S; Ohya T; Mizuno T; Takizawa I; Kunita T; Takata K; Hayashi K; Hino F; Tokumo H; Watanabe T Am J Cardiol; 1995 Jul; 76(2):110A-113A. PubMed ID: 7604783 [TBL] [Abstract][Full Text] [Related]
20. Treatment of combined hyperlipidemia with fluvastatin and gemfibrozil, alone or in combination, does not induce muscle damage. Smit JW; Jansen GH; de Bruin TW; Erkelens DW Am J Cardiol; 1995 Jul; 76(2):126A-128A. PubMed ID: 7604787 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]